Professor Marc Vendrell on a Revolutionary Cancer Treatment: Light-Sensitive Drugs
We need to find molecules or compounds that really enter very, very quickly into the cells that we want to kill but actually don't enter, or enter very slowly in the cells that are surrounding.
Imagine a world where cancer treatments don’t ravage the body. In this episode of 'American Medicine Today', Professor Marc Vendrell, Chair of Translational Chemistry and Biomedical Imaging at the University of Edinburgh, shares groundbreaking research on a new light-sensitive drug designed to target cancer cells while leaving healthy cells unscathed. This innovative drug, described as a 'Trojan Horse', sneaks into cancer cells and destroys them without collateral damage.
Professor Vendrell delves into the science behind this photosensitizer and its potential to revolutionize cancer therapy. Photodynamic therapy, already used for eye conditions, inspired this new approach. The challenge lies in finding molecules that maximize the drug's effectiveness while minimizing harm to surrounding cells. Professor Vendrell's team is gearing up for clinical trials in the next few years, aiming to test this drug across various cancer cell lines.
They’re also exploring exciting possibilities like using light to activate the immune system. This episode offers an engaging and informative discussion that brings hope to cancer patients and their families. With a blend of expert analysis and accessible language, it’s perfect for anyone interested in the latest advancements in cancer treatment. Tune in to hear about the future of cancer therapy and the promising strides being made in medical science.